R2

Cardiac Amyloidosis Has a Diagnostic Grey Zone. A New PET Tracer Could Help Close It

Survival Is No Longer Enough: Mental Health Moves Into Congenital Heart Care

Pembrolizumab Just Lost a Head-to-Head Survival Fight

HER2-Mutant Lung Cancer Just Moved Into First Line

One Psychedelic Dose Is Now a Phase III Argument

The healthcare AI race is shifting from smarter models to safer deployment

MOGAD Is Close to Its First Real Treatment

Britain Wants an AI-Enabled NHS. Scaling Innovation Is Still the Bottleneck

Menstrual Migraine Was Never Just Regular Migraine
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
